Back
Protagonist Therapeutics Vs. Ubiquiti Industry Stock Comparison
Sell
32
PTGX
Protagonist Therapeutics
Last Price:
42.64
Seasonality Move:
12.96%
Buy
60
UI
Ubiquiti
Last Price:
337.08
Seasonality Move:
8.75%
Sell
32
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $43.19. The Score for PTGX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Ubiquiti (UI)
is a Buy
Is Ubiquiti a Buy, Sell or Hold?
- The current Ubiquiti [UI] share price is $349.48. The Score for UI is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- UI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $43.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 37.41 | Sell |
| Chaikin Money Flow: | -566040 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.97 - 47.71) | Sell |
| Bollinger Bands (100): | (36.87 - 46.33) | Buy |
UI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 22.97 | Buy |
| Relative Strength Index (14 RSI): | 85.87 | Buy |
| Chaikin Money Flow: | 79322 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (232.95 - 291.13) | Buy |
| Bollinger Bands (100): | (159.19 - 245.27) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.32 | Sell |
| 20-day SMA: | 46.77 | Sell |
| 50-day SMA: | 45.53 | Sell |
| 200-day SMA: | 35.17 | Buy |
| 8-day EMA: | 45.98 | Sell |
| 20-day EMA: | 46.24 | Sell |
| 50-day EMA: | 44.92 | Sell |
| 200-day EMA: | 36.49 | Buy |
UI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 289.12 | Buy |
| 20-day SMA: | 268.55 | Buy |
| 50-day SMA: | 236.02 | Buy |
| 200-day SMA: | 162.96 | Buy |
| 8-day EMA: | 300.87 | Buy |
| 20-day EMA: | 274.07 | Buy |
| 50-day EMA: | 242.63 | Buy |
| 200-day EMA: | 186.47 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.95 per share.
Ubiquiti Earnings Growth & UI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.01 per share, and an increase next year of $2.99 per share.
Protagonist Therapeutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ubiquiti Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||